NIH
The National Institutes of Health, the primary US government agency for biomedical and public health research funding.
As defined in Conversations With Tyler 2022 Retrospective
Where it comes up · 10
- Jonah Lehrer on Creativity and Imagine3 claims
- Marcia Angell on Big Pharma3 claims
- RTW: Investing Across Healthcare2 claims
- Mark Zuckerberg Interviews Patrick Collison And Tyler Cowen2 claims
- 425 - Are We Prepared For The Next Pandemic2 claims
- Conversations With Tyler 2022 Retrospective1 claim
- Adam Cifu on Ending Medical Reversal1 claim
- 427 - Ai Friends Enemies1 claim
and 2 more
Most important claims · 10 of 17Search all claims for “NIH” →
- In 1980 the NIH spent 12 times more dollars on researchers under 40 than over 50, predominantly funding younger people, but today it spends 5 times more on those over 50 than under 40—an inversion toward a 'gerontocracy' whose effect on scientific productivity is unknown but is an important policy question.Mark Zuckerberg Interviews Patrick Collison And Tyler Cowen
- Because the NIH cannot fund everything and much drug and device research is industry-funded, super-specialists who become experts often have industry affiliations—as trial consultants, trial leaders, or paid/unpaid spokespeople—and a financial stake makes it harder for their recommendations to remain unbiased.Adam Cifu on Ending Medical Reversal
- For a typical drug that costs around $1 billion, NIH funding contributes somewhere between a few hundred thousand dollars and about $5 million, a very small fraction, excluding platform basic science.RTW: Investing Across Healthcare
- An MIT economists' study comparing the NIH to the Howard Hughes Medical Institute found that HHMI scientists—funded for avant-garde research with tolerance for failure—produced more home-run papers (more citations, more new scientific terms) but also far more total failures (papers with 0-1 citations), while equivalent NIH scientists, vetted by a rational process to avoid wasting taxpayer money, produced fewer of both; the lesson is you cannot get the big breakthroughs without tolerating the failures.Jonah Lehrer on Creativity and Imagine
- Rather than fighting over the scraps of Medicaid expansion, the best leverage in healthcare is improving the rate of scientific progress and innovation and reforming the NIH and NSF to be more dynamic and quicker to respond, since advances like mRNA vaccines and treatments for malaria, dengue, and cancer yield huge dividends.Conversations With Tyler 2022 Retrospective
- Government funding through NIH grants covers basic science, and once a project starts looking like a therapeutic in preclinical research, government is no longer the funding source, so private capital typically enters within roughly the first year of a roughly 15-year medicine journey.RTW: Investing Across Healthcare
- Rather than a surgical attack targeting DEI, woke departments, or antisemitism—which would at least have an internal logic—the Trump administration has wholesale destroyed the scientific enterprise, cutting cancer, Alzheimer's, chemistry, biology, physics and computer science funding across the board, with roughly a third of basic research funds cut and the NSF reportedly losing up to half its funding.427 - Ai Friends Enemies
- Cutting basic research funding is a direct hit on the economy because every dollar the NIH spends is estimated to produce $2.50 or more in economic activity, so budget cuts harm the broader innovation ecosystem of industry, academia, and NGOs.425 - Are We Prepared For The Next Pandemic
- As far as can be told there are no books assessing how well the NIH is working—which parts work better or worse, or whether the old NIH was better than the new one—even though this is among the most important questions; the gap shows that major swathes of progress-relevant questions are surprisingly under-investigated despite plentiful good research.Mark Zuckerberg Interviews Patrick Collison And Tyler Cowen
- Because risk-taking is not in the DNA of government agencies like the NIH—whose accountability mandates produce more pretty-good, low-variance research—the conclusion should be less public investment if you want world-changing breakthroughs like cancer cures, which require the high-variance risk tolerance that government cannot supply.Jonah Lehrer on Creativity and Imagine